Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Delaware · 153rd General Assembly (2025-2026) · Joint Resolution

SJR 7: DIRECTING THE STATE EMPLOYEE BENEFITS COMMITTEE AND THE SECRETARY OF HUMAN RESOURCES TO ENGAGE WITH INDEPENDENT CONSULTANTS AND OTHER SUPPLY CHAIN TACTICS FOR COST CONTAINMENT OF PRESCRIPTION DRUGS FOR STATE EMPLOYEES AND RETIREES’ INSURANCE PROGRAMS.

Enacted Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SJR 7 is a joint resolution introduced in the Delaware Senate on May 21, 2025. According to its official title, it concerns: DIRECTING THE STATE EMPLOYEE BENEFITS COMMITTEE AND THE SECRETARY OF HUMAN RESOURCES TO ENGAGE WITH INDEPENDENT CONSULTANTS AND OTHER SUPPLY CHAIN TACTICS FOR COST CONTAINMENT OF PRESCRIPTION DRUGS FOR STATE EMPLOYEES AND RETIREES’ INSURANCE PROGRAMS. Primary sponsor: Ray Seigfried (Democratic), Bryan Townsend (Democratic), Melissa Minor-Brown (Democratic). It lists 8 additional sponsors. Most recent recorded action (August 25, 2025): Signed by Governor.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

This is a Substitute for Senate Joint Resolution No. 7. Like Senate Joint Resolution No. 7, this Substitute directs the State Employees Benefits Committee (SEBC) to utilize specific strategies and policies when interacting and contracting with Pharmacy Benefit Managers (PBM) in order to achieve lower cost pharmaceutical drug benefit plans for the State. This Substitute differs from Senate Joint Resolution No. 7 by clarifying that the SEBC has a duty to consider all of the following strategies and policies when negotiating for pharmaceuticals: 1. Drug cost transparency. 2. Formation of an independent Pharmacy and Therapeutics Committee. 3. Any other supply chain tactics such as a reverse auction or transparency committee. 4. Compacts with other states to negotiate directly with drug manufacturers. 5. Paying no higher price for all drugs negotiated by Medicare. 6. Requiring PBMs disclose administrative expenses for all pharmaceutical drugs. 7. Requiring PBMs bid based on lowest pricing sources, not average wholesale price. 8. Requiring the SEBC be provided all agreements between PBMs and pharmaceutical companies when those agreements are for drugs contracted for on behalf of the SEBC. 9. Performing audits when the SEBC believes it should be entitled to information to achieve transparency or clarity. This Substitute differs from Senate Joint Resolution No. 7 by directing the SEBC to prepare a report by August 1, 2026, to summarize any difficulties in implementing any of these policies and to submit the report to the Governor; the President Pro Tempore of the Senate and Speaker of the House of Representatives, for distribution to all members of the General Assembly; the Director and the Librarian of the Division of Legislative Services; and the Public Archives.

Sponsors

Sponsors by party (alphabetical): Democratic 8 · Republican 3

NameRolePartyChamberDistrict
Ray SeigfriedPrimary sponsorDemocraticSenate5
Bryan TownsendPrimary sponsorDemocraticSenate11
Melissa Minor-BrownPrimary sponsorDemocraticHouse17
Eric BucksonCo-sponsorRepublicanSenate16
Stephanie HansenCo-sponsorDemocraticSenate10
Jeff HilovskyCo-sponsorRepublicanHouse4
Ed OsienskiCo-sponsorDemocraticHouse24
Marie PinkneyCo-sponsorDemocraticSenate13
Dave SokolaCo-sponsorDemocraticSenate8
Jack WalshCo-sponsorDemocraticSenate9
Dave WilsonCo-sponsorRepublicanSenate18

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Signed by Governor
  2. Passed By Senate. Votes: 21 YES
  3. Suspension of Rules in Senate
  4. Passed By House. Votes: 39 YES 1 ABSENT 1 VACANT
  5. Amendment HA 1 to SS 1 - Passed In House by Voice Vote
  6. Reported Out of Committee (Administration) in House with 5 On Its Merits
  7. Not Worked in Committee
  8. Not Worked in Committee
  9. Assigned to Administration Committee in House
  10. Passed By Senate. Votes: 19 YES 2 ABSENT
  11. was introduced and adopted in lieu of SJR 7

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source